phase 1/2 trial of H3B-6545, a novel selective ER covalent antagonist (SERCA) in mHR+BC shows low G3 AEs and good antitumor efficacy to support advancing in further development Erika Hamilton, MD #ASCO24

Wash U fellow Emily Podany speaking on racial differences and inequities. Black people with a PIK3CA mutation were given PIK3CA directed therapy only 6% of the time vs 29% in white people 😳. THIS IS ALMOST CRIMINAL! We must do better to stamp out racism in medicine. #ASCO24

ARX-788 improved PFS vs lapatinib+capecitabine in HER2+ metastatic breast cancer #ASCO24 👀Ocular and 🫁ILD toxicities noted

🧬High response rate 75% with olaparib in pts with PALB2 mutations w metastatic breast cancer #ASCO24 🧬37% response rate with somatic BRCA mutations (more data needed) Definitely see this in clinic and this data will help guide our treatment option

BriaIMT cancer vaccine shows ORR across all breast cancer subtypes HR+ (ORR 10%, CBR 59%), HER2+ (ORR 50%, CBR 100%), TNBC (CBR 36%) CNS responses were observed. #ASCO24

🚨Happening RIGHT NOW at #ASCO24 Our WISH-BREAST poster on Women’s Insights on SexuK Health after Breast Cancer Come stop by!

Poster session fully under way and incredibly impressive work being shared. #ASCO24 Paxman Laila Agrawal, MD Memorial Sloan Kettering Cancer Center Orlando Health

I have been waiting for these RxPonder updates for 2 years!!! Ha!!!! Fantastic presentation by Kevin Kalinsky, MD, MS!!! #ASCO24

🙏 Thank you Vanderbilt-Ingram Cancer Center hematology/oncology fellowship for inviting me to talk about sexual health in women w cancer ❓Did you know that 70% of oncology fellowships have no formal training on female sexual health? Let’s change that! 👏Kudos to Vandy for focusing on this!

Honored to give Grand Rounds Nationwide Children's Hospital on #Burnout and #WorkLifeBalance in medicine and how #mentorship can be a tool to improve these areas! #careerdevelopment #Leadership #MedEd #WomenInMedicine University of Minnesota AMWA Doctors Women In Medicine® UMN Center for Women In Medicine and Science

Our #ASCO24 on #PriorAuthorization denials for pain meds shows that some patients were at the end of life. "Some of those patients died in pain due to prior authorization denial, [it's] truly heartbreaking”. I said what I said. We need to #FixPriorAuth oncologynewscentral.com/article/prior-…

Super fun conversation with awesome colleagues…and yes I talk with my 🙌 …Dana-Farber

Congrats Hatem Fedro Peccatori MD, PhD Ann Partridge MD, MPH et al for reporting in Journal of Clinical Oncology the data presented at #SABCS23 on safety of fertility techniques in patients with #BreastCancer included in #POSITIVE trial..so important results! OncoAlert #bcsm ETOP IBCSG Partners Foundation Link: ascopubs.org/doi/abs/10.120…

Great talk on the work Andreana N. Holowatyj 🇺🇦 is doing on the topic of fertility in early age onset colorectal cancer patients! We have to ensure these conversations are happening with patients as they are being diagnosed! #24SECRCCTN #crcsm #ayacsm

💞Looking forward to speaking at the Twisted Pink Metastatic Breast Cancer Symposium on sexual heath after a breast cancer diagnosis Register here (until 6/17) secure.qgiv.com/for/2024mbcsym…

Thank you to HemOnc Today for highlighting our WISH-BREAST study on sexual health in breast cancer survivors presented at ASCO w/ co-authors Eleonora Teplinsky, MD and Dr. Corinne Menn Check out this article for my Q & A about our study, sexual health, and how I think we can improve 👇

🏅Gold medal to the oncologists and other clinicians who prescribe vaginal estrogen! 🤸Has your cancer team discussed vaginal estrogen? 🏊‍♀️Do you bring it up with your patients?

Check out this upcoming webinar focusing on Oncosexology!

I am honored to be a part of this panel on Advanced Cancer Survivorship at the World Conference on #LungCancer and talk about sexual health after a cancer diagnosis. IASLC #WCLC24